Posted in NEWS Monoclonal antibodies were ‘doing nothing’ against omicron. That’s why FDA pulled its authorization. January 27, 2022 Monoclonal antibodies from drug-makers Regeneron and Eli Lilly have proven ineffective against the omicron variant of COVID-19. http://rssfeeds.usatoday.com/~/679719816/0/usatoday-newstopstories~Monoclonal-antibodies-were-doing-nothing-against-omicron-Thats-why-FDA-pulled-its-authorization/